Cell Therapy Technologies Market by Process Stages (Handling, Cell Processing, Distribution, QC), Product (Software, Consumables, Equipment), Cell Type (Animal, Human Stem & Differentiated), End User, and Region – 2020 to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 23, 2020
Clear
SKU: GMS-2075 Category:

The global market for cell therapy technologies is expected to hit USD 24.2 billion by 2025, rising over the projected period at a CAGR of 13.2 per cent. The main factors driving the growth of this market are rising government investment in cell-based research, the growing number of GMP-certified production facilities and the large number of oncology-oriented cell-based clinical trials.

Cell Therapy Technologies Market by Process Stages (Handling, Cell Processing, Distribution, QC), Product (Software, Consumables, Equipment), Cell Type (Animal, Human Stem & Differentiated), End User, and Region - 2020 to 2025 1

Cell Therapy Technologies Market by Process Stages (Handling, Cell Processing, Distribution, QC), Product (Software, Consumables, Equipment), Cell Type (Animal, Human Stem & Differentiated), End User, and Region - 2020 to 2025 2

Cell Therapy Technologies Market by Process Stages (Handling, Cell Processing, Distribution, QC), Product (Software, Consumables, Equipment), Cell Type (Animal, Human Stem & Differentiated), End User, and Region - 2020 to 2025 3

Cell Therapy Technologies Market by Process Stages (Handling, Cell Processing, Distribution, QC), Product (Software, Consumables, Equipment), Cell Type (Animal, Human Stem & Differentiated), End User, and Region - 2020 to 2025 4

Cell Therapy Technologies Market by Process Stages (Handling, Cell Processing, Distribution, QC), Product (Software, Consumables, Equipment), Cell Type (Animal, Human Stem & Differentiated), End User, and Region - 2020 to 2025 5

Cell Therapy Technologies Market by Process Stages (Handling, Cell Processing, Distribution, QC), Product (Software, Consumables, Equipment), Cell Type (Animal, Human Stem & Differentiated), End User, and Region - 2020 to 2025 6

Cell Therapy Technologies Market by Process Stages (Handling, Cell Processing, Distribution, QC), Product (Software, Consumables, Equipment), Cell Type (Animal, Human Stem & Differentiated), End User, and Region - 2020 to 2025 7

Cell Therapy Technologies Market by Process Stages (Handling, Cell Processing, Distribution, QC), Product (Software, Consumables, Equipment), Cell Type (Animal, Human Stem & Differentiated), End User, and Region - 2020 to 2025 8

1 Global Cell Therapy Technologies Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Cell Therapy Technologies Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Cell Therapy Technologies Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Cell Therapy Technologies Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Cell Therapy Technologies Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Cell Therapy Technologies Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Cell Therapy Technologies Market – By Product (Market Size – & million/billion)
8.1 Consumables
8.2 Equipment
8.3 Systems & Software

9 Global Cell Therapy Technologies Market – By Process
9.1 Cell Processing
9.2 Cell Preservation, Distribution, and Handling
9.3 Process Monitoring and Quality Control

10 Global Cell Therapy Technologies Market – By Cell Type
10.1 Human Cells
10.2 Animal Cells

11 Global Cell Therapy Technologies Market – By End User
11.1 Life Science Research Companies
11.2 Research Institutes

12 Global Cell Therapy Technologies Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Cell Therapy Technologies Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Cell Therapy Technologies Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Thermo Fisher Scientific, Inc.
14.3 Merck KGaA
14.4 Terumo Bct, Inc. (A Subsidiary of Terumo Corporation)
14.5 Becton, Dickinson and Company
14.6 Lonza Group
14.7 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
14.8 Miltenyi Biotec GmbH
14.9 GE Healthcare
14.10 Sartorius
14.11 Stemcell Technologies
14.12 Company 11 & more

15 Global Cell Therapy Technologies Market – Appendix
15.1 Sources
15.2 Abbreviations